Month: July 2007
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs…
(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…